Continuum Advisory, LLC Immunocore Holdings PLC Transaction History
Continuum Advisory, LLC
- $727 Million
- Q1 2025
A detailed history of Continuum Advisory, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Continuum Advisory, LLC holds 47 shares of IMCR stock, worth $1,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 47
-0.0%
Holding current value
$1,505
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$226 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$196 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$156 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$85.8 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.4 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...